To investigate the fate of SEMA4B in vivo, we injected 2 × 106 shSEMA4B/shCtrl-expressing bioluminescent LLC tumor cells subcutaneously to thigh of C57BL/6 mice to monitor tumor growth. This evidence concerns the gene SEMA4B and neoplasm.